Skip to main content
logo
Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India flag India · Delayed Price · Currency is INR
451.35
-12.65 (-2.73%)
At close: Feb 13, 2026

NSE:AKUMS Revenue

Akums Drugs and Pharmaceuticals had revenue of 11.60B INR in the quarter ending December 31, 2025, with 14.76% growth. This brings the company's revenue in the last twelve months to 42.60B, up 6.22% year-over-year. In the fiscal year ending March 31, 2025, Akums Drugs and Pharmaceuticals had annual revenue of 41.21B, down -1.45%.

Revenue (ttm)
42.60B
Revenue Growth
+6.22%
P/S Ratio
1.60
Revenue / Employee
5.73M
Employees
7,536
Market Cap
69.10B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202541.21B-605.31M-1.45%
Mar 31, 202441.82B5.24B14.34%
Mar 31, 202336.57B-180.32M-0.49%
Mar 31, 202236.75B9.49B34.81%
Mar 31, 202127.26B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Alembic Pharmaceuticals72.67B
Strides Pharma Science47.26B
NATCO Pharma45.63B
Eris Lifesciences30.59B
Alivus Life Sciences25.12B
Aarti Pharmalabs18.01B
Innova Captab14.97B
Cohance Lifesciences10.58B
Revenue Rankings

Akums Drugs and Pharmaceuticals News

More News